David Lebwohl
Chief Medical Officer
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Intellia Therapeutics, Inc. (NTLA)
Source not stated
Start not stated–2026-08-07
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Intellia Therapeutics, Inc. (NTLA) | Executive Vice President, Chief Medical Officer | $536,000 | $1,984,724 |
| 2024 | Intellia Therapeutics, Inc. (NTLA) | Executive Vice President, Chief Medical Officer | $520,000 | $5,577,407 |
| 2023 | Intellia Therapeutics, Inc. (NTLA) | Executive Vice President, Chief Medical Officer | $495,000 | $4,257,962 |
| 2022 | Intellia Therapeutics, Inc. (NTLA) | Executive Vice President, Chief Medical Officer | $475,300 | $3,716,964 |
| 2021 | Intellia Therapeutics, Inc. (NTLA) | Executive Vice President, Chief Medical Officer | $458,300 | $4,265,559 |
| 2020 | Intellia Therapeutics, Inc. (NTLA) | Executive Vice President, Chief Medical Officer | $298,378 | $2,078,788 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.